| Previous Section | Index | Home Page |
26 Mar 2008 : Column 219W—continued
The Department does collect the number of radiographers and radiologists working in the NHS. Data for the West Midlands and the NHS organisations which cover the Tamworth area have been set out in the following table, including figures for 1997 and the three most recent years for which data are available.
| NHS hospital and community health services: Qualified diagnostic radiography staff and medical staff within the radiology group of specialties in England by strategic health authority (SHA) area and specified organisation as at 30 September each specified year | ||||
| Headcount | ||||
| 1997 | 2004 | 2005 | 2006 | |
| n/a = Not applicable (1) In 2006 Burntwood, Lichfield and Tamworth PCT, Cannock Chase PCT, East Staffordshire PCT and South Western Staffordshire PCT merged to form the South Staffordshire PCT. Figures prior to 2006 are an aggregate of these four predecessor organisations. Note: More accurate validation processes in 2006 have resulted in the identification and removal of 9,858 duplicate non-medical staff records out of the total work force figure of 1.3 million in 2006. Earlier years’ figures could not be accurately validated in this way and so will be slightly inflated. The level of inflation in earlier years’ figures is estimated to be less than 1 per cent. of total across all non-medical staff groups for headcount figures (and negligible for full time equivalents). This should be taken into consideration when analysing trends over time. Sources: The Information Centre Non Medical Workforce Census. The Information Centre for health and social care Medical and Dental Workforce Census. | ||||
Radiotherapy
Bill Wiggin: To ask the Secretary of State for Health pursuant to the answer of 3 March 2008, Official Report, columns 2105-6W, on radiotherapy, how many patients had (a) part funded and (b) fully funded proton therapy abroad; in which countries patients have received proton therapy treatment; and if he will make a statement. [193112]
Ann Keen: Information on the number of patients who have funded or part funded proton beam therapy abroad is not collected centrally.
Patients have been referred to Switzerland for proton beam therapy.
From April 2008 proton therapy for suitable cancers other than eye cancers, which can be treated in the United Kingdom, will be nationally commissioned from overseas. In the longer term, the Department will consider options for providing modern proton therapy services in this country.
Secure Psychiatric Units: Capacity
Jenny Willott: To ask the Secretary of State for Health what the maximum capacity of provision for (a) NHS and (b) independent sector secure mental healthcare places has been, broken down by establishment, in each of the last 10 years; and if he will make a statement. [196072]
Mr. Ivan Lewis: The information is not available in the form requested. The available data are collected on the numbers of mental health and learning disability secure unit beds in national health service units, and do not include independent sector beds. The data are not broken down by establishment.
Data on the average daily number of mental health secure unit beds, and learning disability secure unit beds in NHS units in England over the last ten years are set out in the following table.
| Average daily number of mental health and learning disability secure unit beds in NHS units | |||||
| 1997-98 | 1998-99 | 1999-2000 | 2000-01 | 2001-02 | |
| Average daily number of mental health and learning disability secure unit beds in NHS units | |||||
| 2002-03 | 2003-04 | 2004-05 | 2005-06 | 2006-07 | |
| (1) The definitions of mental health and learning disability secure unit beds, for the purposes of the KH03 annual beds collection, are: Mental illness—Other ages, secure unit an AGE GROUP INTENDED of National Code 8 ‘Any age’, a BROAD PATIENT GROUP CODE of National Code 5 ‘Patients with mental illness’ and a CLINICAL CARE INTENSITY of National Code 51 ‘for intensive care: specially designated ward for patients needing containment and more intensive management This is not to be confused with intensive nursing where a patient may require one to one nursing while on a standard ward’. Learning disabilities—Other ages, secure unit an AGE GROUP INTENDED of National Code 8 ‘Any age’, a BROAD PATIENT GROUP CODE of National Code 6 ‘Patients with learning difficulties’ and a CLINICAL CARE INTENSITY of National Code 61 ‘designated or interim secure unit’. Source: Department of Health Dataset KH03(1). | |||||
These figures do not represent the full level of secure services available to the NHS. “Low secure” mental health services are not consistently defined and may well fall outside the definitions used for this data collection. This means that the figures above mainly show the numbers in high and medium secure mental health services in NHS units. These figures also only show NHS beds and not those commissioned by the NHS and provided by independent sector providers.
Secure Psychiatric Units: Finance
Jenny Willott: To ask the Secretary of State for Health how much has been spent on (a) NHS and (b) independent sector secure mental healthcare places for offenders in each of the last 10 years, broken down by (i) primary care trust and (ii) local health board; and if he will make a statement. [196069]
Mr. Ivan Lewis: The information is not available in the form requested. Information on spending on low and medium secure services is not collected in this format, and is not broken down by establishment.
Information is available on the total spend on high secure services for the last five years, based on service level agreements between the high security hospitals and commissioners(1). This is set out in the following table. The spending figures include offenders and non-offenders.
(1) The figures exclude Dangerous and Serious Personality Disorder programme patients.
| Total spend on high secure services in £000 | |
Seroxat
David Taylor: To ask the Secretary of State for Health what assessment he has made of GlaxoSmithKline's (GSK) use in the UK of negative results from Seroxat trials; and who the (a) UK and (b) non-UK based professional registrants were who had (i) managerial and (ii) clinical responsibility for GSK's nine seroxat trials involving children between 1994 and 2002. [196847]
Dawn Primarolo: A detailed criminal investigation was undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA), into whether GlaxoSmithKline withheld information from paediatric clinical trials of their drug Seroxat. The report on the outcome of the investigation has been published and is available in the Library and also on the MHRA website at:
The MHRA does not normally release personal data, supplied in an expectation of confidence, in accordance with Sections 38 and 40 of the Freedom of Information Act 2000.
Seroxat: Children
David Taylor: To ask the Secretary of State for Health with reference to the Written Ministerial Statement of 8 March 2008, Official Report, column 121WS, on GlaxoSmithKline (MHRA investigation), what discussions he has had with the Chief Executive of the Medicines and Healthcare Regulatory Authority on its investigation of the trials of Seroxat involving children between 1994 and 2002. [196777]
Dawn Primarolo [holding answer 25 March 2008]: Departmental Ministers were briefed on a regular basis on the progress of the investigation into the compliance of GlaxoSmithKline with relevant legislation, and on the conclusion of the investigation, in advance of the written ministerial statement.
Suicide: Young People
Dr. Francis: To ask the Secretary of State for Health (1) what recent discussions he has had with appropriate agencies on suicides amongst young people; and if he will make a statement; [196525]
(2) whether the subject of assistance to suicide prevention amongst young people was on the agenda of recent Ministerial level meetings with the Welsh Assembly Government; whether any cross-border services are envisaged; and if he will make a statement. [196783]
Mr. Ivan Lewis:
There have been no discussions with appropriate agencies nor have discussions taken place at ministerial level with the Welsh Assembly Government about suicides among young people. Officials responsible for implementing the National Suicide Prevention Strategy for England continue to engage with relevant agencies and organisations in considering appropriate measures to take to reduce the risk of suicide among the general population, including young people. In addition, the Suicide Prevention Strategy Advisory Group, chaired by Professor Louis Appleby, meets twice yearly and provides leadership,
expert advice and guidance on implementation of the suicide prevention strategy. Membership of this group includes researchers and representatives of Samaritans and PAPYRUS, an organisation committed to the prevention of young suicide.
In addition, the five nations, representing England, Scotland, Northern Ireland, Wales and Republic of Ireland, have established a suicide prevention strategies coordinating group to share information, research and evidence on suicide prevention actions among the five nations. This group meets on a regular basis.
| Next Section | Index | Home Page |